In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

GPT-5.4 Pro cracked a conjecture in number theory that had stumped generations of mathematicians, using a proof strategy that ...

In an ancient dwarf galaxy on the outskirts of the Milky Way, astronomers have discovered one of the most chemically primitive stars ever seen. Named PicII-503, the star’s extreme lack of heavy ...

An understanding of how to use Pythagoras’ theorem to find missing sides in a right-angled triangle is essential for applying the theorem in different contexts. (3,1) is the coordinate that is 3 along ...

Emmy Noether was a mathematician who discovered perhaps the most profound idea in contemporary physics. Noether’s theorem, which she formulated in 1915, says that symmetries in the universe give rise ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals insiders completed 5 transactions totaling $366,367.08. Activity included 2 stock sales and 1 tax payment, with the largest single transaction at $149,367.08. Updated 3h ago ...